296 results on '"Sitrin, Robert"'
Search Results
2. Contributors
3. Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization.
4. Quantification of trivalent non-replicating rotavirus vaccine antigens in the presence of aluminum adjuvant
5. Animal testing for vaccines. Implementing replacement, reduction and refinement: challenges and priorities
6. Choice of adjuvant and antigen composition alters the immunogenic profile of a SARS-CoV-2 subunit vaccine
7. Characterizing and Minimizing Aggregation and Particle Formation of Three Recombinant Fusion-Protein Bulk Antigens for Use in a Candidate Trivalent Rotavirus Vaccine
8. Effect of Aluminum Adjuvant and Preservatives on Structural Integrity and Physicochemical Stability Profiles of Three Recombinant Subunit Rotavirus Vaccine Antigens
9. Recombinant Subunit Rotavirus Trivalent Vaccine Candidate: Physicochemical Comparisons and Stability Evaluations of Three Protein Antigens
10. Separation Methodology
11. Analytical Comparability Assessments of 5 Recombinant CRM197 Proteins From Different Manufacturers and Expression Systems
12. Recombinant Virus-like Particle Protein Vaccines
13. Positive airway pressure therapy for sleep-disordered breathing confers short-term benefits to patients with spinal cord injury despite widely ranging patterns of use
14. Simplified Approach to Diagnosing Sleep-Disordered Breathing and Nocturnal Hypercapnia in Individuals With Spinal Cord Injury
15. Chapter 6 - Vaccine Manufacturing
16. Concordance of in vitro and in vivo measures of non-replicating rotavirus vaccine potency
17. Home-Based Overnight Transcutaneous Capnography/Pulse Oximetry for Diagnosing Nocturnal Hypoventilation Associated With Neuromuscular Disorders
18. Disassembly and reassembly improves morphology and thermal stability of human papillomavirus type 16 virus-like particles
19. In-depth process understanding of RECOMBIVAX HB® maturation and potential epitope improvements with redox treatment: Multifaceted biochemical and immunochemical characterization
20. Factor XII stimulates ERK1/2 and Akt through uPAR, integrins, and the EGFR to initiate angiogenesis
21. Measurement and Decomposition Kinetics of Residual Hydrogen Peroxide in the Presence of Commonly used Excipients and Preservatives
22. FcγRI ligation leads to a complex with BLT1 in lipid rafts that enhances rat lung macrophage antimicrobial functions
23. Relationship between tightness of binding and immunogenicity in an aluminum-containing adjuvant-adsorbed hepatitis B vaccine
24. Recombinant Virus-like Particle Protein Vaccines
25. Characterization of virus-like particles in GARDASIL® by cryo transmission electron microscopy
26. Hexavalent IPV-based combination vaccines for public-sector markets of low-resource countries
27. A practical approach to optimization and validation of a HPLC assay for analysis of polyribosyl-ribitol phosphate in complex combination vaccines
28. Development and application of a quantitative RT-PCR potency assay for a pentavalent rotavirus vaccine (RotaTeq ®)
29. Home-Based Diagnosis of Nocturnal Hypoventilation in Neuromuscular Disorders
30. An Obligate Role for Membrane-Associated Neutral Sphingomyelinase Activity in Orienting Chemotactic Migration of Human Neutrophils
31. Migrating Human Neutrophils Exhibit Dynamic Spatiotemporal Variation in Membrane Lipid Organization
32. Visualization of discrete L1 oligomers in human papillomavirus 16 virus-like particles by gel electrophoresis with Coomassie staining
33. Quantitative nuclear magnetic resonance analysis and characterization of the derivatized Haemophilus influenzae type b polysaccharide intermediate for PedvaxHIB
34. Effect of Alternative Aluminum Adjuvants on the Absorption and Immunogenicity of HPV16 L1 VLPs in Mice
35. Evaluation of the Thermal Stability of Gardasil®
36. Maturation of Recombinant Hepatitis B Virus Surface Antigen Particles
37. Expression of plasminogen activator and plasminogen activator inhibitor mRNA in human fibroblasts grown on different substrates
38. Lipid Raft Compartmentalization of Urokinase Receptor Signaling in Human Neutrophils
39. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children
40. Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity
41. Wegener's Granulomatosis in the Elderly*
42. The Urokinase Receptor Is Required for Human Monocyte Chemotaxis In Vitro
43. Surface Phosphophilicity of Aluminum-Containing Adjuvants Probed by Their Efficiency for Catalyzing the PO Bond Cleavage with Chromogenic and Fluorogenic Substrates
44. Home-Based Diagnosis and Management of Sleep-Related Breathing Disorders in Spinal Cord Injury
45. Expression of Urokinase-type Plasminogen Activator by Rat Pulmonary Alveolar Epithelial Cells
46. Analytical Comparability Assessments of 5 Recombinant CRM 197 Proteins From Different Manufacturers and Expression Systems
47. Evaluation of the purity of a purified, inactivated hepatitis A vaccine (VAQTA TM)
48. Haemophilus influenzae type b conjugate vaccine stability: catalytic depolymerization of PRP in the presence of aluminum hydroxide
49. Sleep disordered breathing in spinal cord injury: A systematic review
50. Proteolytic enzymes and arachidonic acid metabolites produced by MRC-5 cells on various microcarrier substrates
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.